PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

Valuation of PAR, page-4

  1. 97 Posts.
    lightbulb Created with Sketch. 9
    My thinking is say earnings per share at $18.12 then you work out a rough share price as per PE ratio.
    I know biotechs run at around 40 per PE ratio but let's take a more modest ratio of 20.
    $18.12 x 20 = $362 share price wow
    Can PAR be a 100 bagger?
    Now, this is basic maths and I'm sure there are a lot more details to be ironed out such as distribution costs, royalties, costs, wages, etc.
    If this all plays out in 5-10 years I may be able to retire early.
    DYOR
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.